about
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemiaInterferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML PatientsGenotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in ErythroleukemiaPU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation.Epigenetic control of SPI1 gene by CTCF and ISWI ATPase SMARCA5.5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity.
P50
Q28304835-5848FB6C-A461-4EB0-96F3-65DC97445AE2Q28552307-EF4F2EE6-E566-46C7-BBEE-B30D5942FCAFQ33577088-89348402-9B01-44C7-A79F-23F9F4B90690Q35969056-8FDEE27B-0C8A-4AA6-989D-0B5E6DE0A0F4Q38700890-110425A2-74AE-4EFE-8108-3D21C3F596D4Q39026960-A7950AC7-D447-4AE9-96CE-26524FFEBA5AQ39395000-7B36979E-2C61-4E9A-8D38-7FBC61569D51
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Nikola Curik
@en
Nikola Curik
@nl
type
label
Nikola Curik
@en
Nikola Curik
@nl
prefLabel
Nikola Curik
@en
Nikola Curik
@nl
P31
P496
0000-0002-5876-1326